Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Akagera Medicines Logo
Akagera Medicines CB Rank
643795
Heat Score
63
Akagera Medicines is a biotechnology company.
Private Boston, Massachusetts, United States1-10 www.akageramedicines.com
Biotechnology
Overview

Akagera Medicines
Heat Score
63

Growth Score
pts
in past quarter
Heat Score 63
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Akagera Medicines

CB Rank
643795
Akagera Medicines is a biotechnology company.
Private Boston, Massachusetts, United States1-10 www.akageramedicines.com
Biotechnology

Key People

  • Photo of Mark Hayes
    Mark Hayes: Vice President of Research
    Past Role: ZoneOne Pharma, Co-Founder and Senior Scientist

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Liposomal Nanotherapeutics for Tuberculosis
A series of novel liposomal formulations of antibacterial drugs designed to treat tuberculosis by enhancing drug delivery and uptake into macrophages.
Vaccine Candidates
Development of vaccine candidates for Tuberculosis, Lassa Fever, HIV, RSV, and Influenza using a targeted lipid nanoparticle delivery system.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Board Members and Advisors 1 Contacts 3

Employee Profiles

Board Members and Advisors

News
Technology
View Tech Report

Monthly Web Visits

606
229.35%
 in past month

IT Spend

$38.1KThis year, Akagera Medicines is projected to spend $38.1K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Bloomberg L.P. Logo
Bloomberg L.P.
93
Ballast Water Logo
Ballast Water
77
LinkedIn Logo
LinkedIn
66

Active Website Tech Count

3Akagera Medicines is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  COVID-19.
Sub-Organizations
Frequently Asked Questions

Where is Akagera Medicines's headquarters? Akagera Medicines is located in Boston, Massachusetts, United States.Who are Akagera Medicines's competitors? Alternatives and possible competitors to Akagera Medicines may include Pfizer, Moderna, and  Sanofi.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|